Concepedia

Hristo Iliev

HI

4

Publications

294

Citations

4

H-Index

2017

Active since

Affiliations

Boehringer Ingelheim (Germany)(Current)

Hristo Iliev is an author at Boehringer Ingelheim (Germany) specializing in medicine, renal disease, and diabetes.

Top concepts

Publications per year

2017–2024

4

Publications

4

Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I–III Clinical Trials

Sven Köhler, Cordula Zeller, Hristo Iliev et al. · Advances in Therapy · 2017 · 191 citations · Full text

Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus

Ona Kinduryte Schorling, Douglas Clark, Isabella Zwiener et al. · Advances in Therapy · 2020 · 45 citations · Full text

Effect of Avenciguat on Albuminuria in Patients with CKD

Hiddo J.L. Heerspink, David Cherney, Abdul Halim Abdul Gafor et al. · Journal of the American Society of Nephrology · 2024 · 31 citations · Full text

, , +13

Safety and effectiveness of empagliflozin in Japanese patients with type 2 diabetes: interim analysis from a post-marketing surveillance study

Kohei Kaku, Rina Chin, Yusuke Naito et al. · Expert Opinion on Drug Safety · 2019 · 27 citations · Full text

Rows per page

1–4 of 4